Concepedia

Stefania Di Marco

SD

32

Publications

9.5K

Citations

28

H-Index

1991

Active since

Affiliations

Novartis (Switzerland)(Current)

IRBM Science Park

University of Oxford

Institute of Molecular Biology and Pathology

Jenner Institute

Stefania Di Marco is an author at Novartis (Switzerland) specializing in natural sciences, molecular biology, and medicine.

Top concepts

Publications per year

1991–2021

32

Publications

32

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2021 · 1.2K citations · Full text

Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor

Alessandro Vannini, Cinzia Volpari, Gessica Filocamo et al. · Proceedings of the National Academy of Sciences · 2004 · 620 citations · Full text

, , +17

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

Katie Ewer, Tommy Rampling, Navin Venkatraman et al. · New England Journal of Medicine · 2015 · 353 citations · Full text

Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8–substrate complex

Alessandro Vannini, Cinzia Volpari, Paola Gallinari et al. · EMBO Reports · 2007 · 252 citations · Full text

, , +11

Rows per page

1–5 of 32